Wall Street Just Put a Monster Target on Micron. Is the Stock Still Too Cheap?

Micron posted a major fiscal Q2 beat, with revenue of $23.86B vs. $19.51B consensus and non-GAAP EPS of $12.20 vs. $8.73 expected, while gross margin expanded to 74.4% and free cash flow rose 837% year over year to $6.90B. Management guided fiscal Q3 revenue to $33.50B, EPS to $19.15, and gross margin to ~81%, and the board raised the dividend 30% to $0.15 per share with $650M in buybacks. The article highlights a bullish but contested setup: Susquehanna’s $1,750 price target is far above the $939 3-month consensus and implies roughly 2x upside from the current ~$891 stock price.

Analysis

The market is effectively re-rating Micron from a cyclical memory producer into a constrained AI infrastructure supplier, and that is the only reason a double-digit forward multiple can coexist with a near-parabolic share price. The second-order implication is that the real scarcity value is not "memory" broadly, but qualified high-end supply tied to next-gen platforms; that should keep pricing power elevated for HBM-capable vendors while creating a much harsher bifurcation versus lower-tier DRAM/NAND exposure if the cycle turns.

NVDA certification is strategically more important than the headline margin print because it reduces customer qualification risk and makes Micron harder to displace in the next procurement round. That tends to pull forward capex, inventory build, and contract visibility across the ecosystem, which can temporarily support suppliers and equipment names even if end-demand growth later normalizes. The flip side is that this also incentivizes capacity additions by every incumbent, so the market may be underestimating how quickly today’s exceptional gross margins can compress once supply responses hit in 2-4 quarters.

The consensus gap is telling: this is not a classic mispriced value setup, it is a regime-change bet where the Street is unwilling to extrapolate peak AI scarcity into 2026-2027. The bullish case is that qualification plus multi-quarter demand visibility creates a longer terminal profit pool than skeptics assume; the bearish case is that investors are paying peak-cycle multiples for peak-cycle margins. The key catalyst is not the current quarter, but whether management can defend guide quality into the next fiscal year without signaling any deceleration in HBM tightness.

From a risk perspective, the stock is vulnerable to any hint of order normalization, customer inventory digestion, or aggressive capex commentary from peers, and that risk likely expresses over weeks to months rather than days. A sharp multiple reset would probably happen before earnings are actually missed, simply on softer forward commentary. That makes this more of a sentiment and guidance trade than a clean fundamental value long at current levels.

Key Decisions for Investors

• Take partial profits in MU into strength over the next 1-3 weeks; risk/reward worsens materially if the stock is already discounting peak-cycle margins and the next catalyst is only confirmation rather than acceleration.
• If long MU, pair it against a basket short of lower-quality memory or broader semi names with less AI qualification leverage; the trade is to isolate HBM scarcity rather than beta to semis.
• For new exposure, buy MU call spreads 2-4 months out rather than outright stock to capture continued multiple expansion while limiting downside if guidance quality softens.
• Use NVDA as a relative long versus other AI hardware beneficiaries only if you believe certification drives share gains without triggering an immediate supply response; otherwise keep NVDA exposure hedged since it may be the first name to absorb any HBM supply normalization signal.
• Set a trigger to de-risk on any commentary implying 2027 capacity additions are closing the gap; that is the earliest point where the market will start pricing margin mean reversion, likely before the numbers show it.